Long-term eltrombopag for bone marrow failure depletes iron.


Journal

American journal of hematology
ISSN: 1096-8652
Titre abrégé: Am J Hematol
Pays: United States
ID NLM: 7610369

Informations de publication

Date de publication:
01 06 2022
Historique:
revised: 16 03 2022
received: 07 02 2022
accepted: 17 03 2022
pubmed: 22 3 2022
medline: 6 5 2022
entrez: 21 3 2022
Statut: ppublish

Résumé

Eltrombopag (EPAG) has been approved for the treatment of aplastic anemia and for immune thrombocytopenia, and a subset of patients require long-term therapy. Due to polyvalent cation chelation, prolonged therapy leads to previously underappreciated iron depletion. We conducted a retrospective review of patients treated at the NIH for aplastic anemia, myelodysplastic syndrome, and unilineage cytopenias, comparing those treated with EPAG to a historical cohort treated with immunosuppression without EPAG. We examined iron parameters, duration of therapy, response assessment, relapse rates, and common demographic parameters. We included 521 subjects treated with (n = 315) or without EPAG (n = 206) across 11 studies with multiyear follow-up (3.6 vs. 8.5 years, respectively). Duration of EPAG exposure correlated with ferritin reduction (p = 4 × 10

Identifiants

pubmed: 35312200
doi: 10.1002/ajh.26543
pmc: PMC9081201
mid: NIHMS1790479
doi:

Substances chimiques

Benzoates 0
Hydrazines 0
Pyrazoles 0
Ferritins 9007-73-2
Iron E1UOL152H7
eltrombopag S56D65XJ9G

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

791-801

Subventions

Organisme : Intramural NIH HHS
ID : ZIA HL006186
Pays : United States

Informations de copyright

Published 2022. This article is a U.S. Government work and is in the public domain in the USA.

Références

Am J Hematol. 2017 Jun;92(6):E88-E91
pubmed: 28240793
Int J Hematol. 2012 Feb;95(2):149-59
pubmed: 22193844
Int J Hematol. 2015 Jan;101(1):13-22
pubmed: 25430083
Am J Hematol. 2014 May;89(5):467-9
pubmed: 24415649
Blood. 2017 Oct 26;130(17):1923-1933
pubmed: 28864815
Lancet Haematol. 2019 Nov;6(11):e562-e572
pubmed: 31474546
PLoS One. 2018 Dec 3;13(12):e0208102
pubmed: 30507954
Lancet. 2015 Oct 24;386(10004):1649-58
pubmed: 26231455
Leuk Res. 2013 Mar;37(3):327-32
pubmed: 23259989
N Engl J Med. 2007 Nov 29;357(22):2237-47
pubmed: 18046028
Transfusion. 2010 Jul;50(7):1568-70
pubmed: 20230535
N Engl J Med. 2011 Aug 4;365(5):430-8
pubmed: 21812672
Lancet. 2011 Jan 29;377(9763):393-402
pubmed: 20739054
Blood. 2017 Mar 16;129(11):1428-1436
pubmed: 28096088
Lancet. 2009 Feb 21;373(9664):641-8
pubmed: 19231632
Adv Exp Med Biol. 2015;866:83-9
pubmed: 26022903
Br J Haematol. 2006 Jun;133(6):606-11
pubmed: 16704434
Blood. 2012 Aug 9;120(6):1185-96
pubmed: 22517900
Br J Haematol. 1996 Aug;94(2):288-99
pubmed: 8759889
Hematology Am Soc Hematol Educ Program. 2008;:166-75
pubmed: 19074076
Acta Haematol. 2013;129(2):72-7
pubmed: 23154600
Blood. 2012 Jan 12;119(2):345-54
pubmed: 22067384
Br J Haematol. 2021 Feb;192(3):605-614
pubmed: 33410523
Cells. 2021 Mar 26;10(4):
pubmed: 33810313
Haematologica. 2009 Mar;94(3):348-54
pubmed: 19181786
Haematologica. 2013 Jul;98(7):1045-8
pubmed: 23585526
Lancet Haematol. 2015 Aug;2(8):e315-25
pubmed: 26688484
JAMA. 2003 Mar 5;289(9):1130-5
pubmed: 12622583
Bone Marrow Transplant. 2012 Jan;47(1):60-4
pubmed: 21399668
Blood. 2014 Oct 30;124(18):2820-3
pubmed: 25185712
Blood. 2019 Jun 13;133(24):2575-2585
pubmed: 30992268
Eur J Haematol. 2014 Jun;92(6):527-36
pubmed: 24580147
N Engl J Med. 2017 Apr 20;376(16):1540-1550
pubmed: 28423296
Blood. 2018 May 24;131(21):2399-2402
pubmed: 29632023
Eur J Haematol. 2013 Sep;91(3):249-61
pubmed: 23772810
Turk J Haematol. 2020 Mar 17;37(3):139-144
pubmed: 32181630
Clin Ther. 2009 Apr;31(4):764-76
pubmed: 19446149
Blood. 2017 Nov 23;130(21):2257-2264
pubmed: 29167174
Acta Haematol. 2008;120(2):70-4
pubmed: 18827475
Am J Hematol. 2008 Aug;83(8):611-3
pubmed: 18442062
N Engl J Med. 2012 Jul 5;367(1):11-9
pubmed: 22762314
Sci Transl Med. 2018 Sep 12;10(458):
pubmed: 30209246
Leuk Res. 2011 May;35(5):566-70
pubmed: 21185078
Blood Adv. 2020 Apr 28;4(8):1700-1710
pubmed: 32330244
Leuk Lymphoma. 2017 Nov;58(11):2752-2754
pubmed: 28482720
J Clin Oncol. 2012 Jun 10;30(17):2134-9
pubmed: 22547607
PLoS One. 2015 Mar 16;10(3):e0120219
pubmed: 25774923

Auteurs

David J Young (DJ)

Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, USA.

Xing Fan (X)

Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, USA.

Emma M Groarke (EM)

Hematology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, USA.

Bhavisha Patel (B)

Hematology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, USA.

Ronan Desmond (R)

Hematology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, USA.
Department of Haematology (Laboratory), Tallaght University Hospital, Dublin, Ireland.

Thomas Winkler (T)

Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, USA.

Andre Larochelle (A)

Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, USA.

Katherine R Calvo (KR)

Department of Laboratory Medicine, Clinical Center, NIH, Bethesda, Maryland, USA.

Neal S Young (NS)

Hematology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, USA.

Cynthia E Dunbar (CE)

Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH